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Background: Intravenous injection of narcotic stimulants affects many cellular functions 
relevant for the pathophysiological mechanisms of heart failure. There is considerable evi-
dence that mast cells (MCs), TNF-α, and cell death play crucial roles in the pathogenesis and 
progression of cardiac arrest. In this study, we examined and compared the participation of 
MCs, TNF-α, apoptosis and necrosis in the heart of drug-related fatalities and the victims of 
sudden death due to the cardiac failure or aortic dissection.
Methods and results: Serum level of postmortem tryptase was determined in all study subjects 
that consisted of 50 autopsy cases: 30 drug overdose fatalities which were further divided into 
two groups with high and low level of tryptase, and 20 cases of sudden natural death (SND). 
The distribution proﬁ  le of cardiac inﬁ  ltrated-MCs and production patterns of TNF and C9 
(necrotic marker) were investigated immunohistochemically. In situ-detection of apoptosis with 
TUNEL was applied to the heart sections. The level of tryptase was elevated (45 µg/L) in the 
drug fatalities but remained below the cut-off value in SND. In the myocardium of overdose 
victims, MC-inﬁ  ltration and degranulation were signiﬁ  cantly increased as well as production 
of myocytic TNF-α compared with the SND cases. The expressions proﬁ  le of myocytic TNF 
varied between the groups. Apoptotic myocytes were seen more frequently in the SND group 
while necrosis was more evident in the heart of drug-related fatalities.
Conclusion: Mast cells are recruited and activated in the heart of drug-associated deaths and 
the myocytes are the main source of TNF-α with the ability of different production patterns. 
The high degree of MC degranulation and the elevated levels of tryptase together with the 
pathological changes in heart of drug-related victims resemble that of the anaphylactic deaths 
as demonstrated in our previous study.
Keywords: mast cells, TNF-α, apoptosis, sudden death, narcotic stimulant
Introduction
Possible roles of cardiac mast cells (MCs), have been suggested in mediating 
injury in myocardial ischemia (Kovanen et al 1995; Somasundaram et al 2005) and 
involvement in regulating ﬁ  brous tissue deposition and scar formation in healing 
infarcts (Frangogiannis et al 2002; Somasundaram et al 2005). MCs are divided 
into three different types according to the content of tryptase (T) and Chymase (C); 
MCTC (mostly in connective tissue), MCT (in mucosal), and MCC that contains only 
chymase (Irani et al 1989; Yao et al 2003). Histochemical studies indicate rapid mast 
cell degranulation and mediator release after myocardial ischemia (Edston 1997). The 
complement split-product C5a, adenosine, and reactive oxygen may represent the 
stimuli responsible for initiation of mast cell degranulation (Linden 1994).
The symptoms of heroin intoxication with respiratory and circulatory shock 
and pulmonary edema, resembles anaphylaxis. The high concentration of postmor-
tem blood tryptase (Edston et al 1997) in many heroin cases indicates that death was Vascular Health and Risk Management 2007:3(6) 1054
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preceded by a systemic mast cell degranulation (Edston et al 
1997; Schwartz et al 1989). However, the serum tryptase 
level remains normal in the victims of acute myocardial 
infarction and other causes of sudden cardiovascular deaths 
(van Haelst et al 2001). MCs are identiﬁ  ed as the only source 
of preformed and immunologically induced tumor necrosis 
factor (TNF)-α, a proinﬂ  ammatory mediator (Gordon et al 
1990). MC degranulation appears to be conﬁ  ned to the 
ischemic area and results in rapid release of TNF-α and 
subsequent induction of an inﬂ  ammatory cascade crucial 
for the pathophysiological mechanisms of cardiac arrest 
(Blancke et al 2005). Preliminary ﬁ  ndings show that patients 
with heart failure have increased levels of TNF-α compared 
with healthy controls (Levine et al 1990) and this is associ-
ated with the severity of cardiac malfunction (Levine et al 
1990; Anker et al 1997). However, to date there is no direct 
evidence that increased levels of TNF-α is due to the over-
production of cardiac myocytes.
The two major forms of cell death; apoptosis, which is 
the physiologic form of cell death; and necrosis, an acci-
dental form of cell death; are both induced by the action of 
TNF-α. The evidence for a TNF-derived mast cell-mediated 
myocardial apoptosis in patients with heart failure supports 
the involvement of apoptosis in the pathophysiology of heart 
failure (Rossig et al 2000; Zheng et al 2006).
As potent sympathetic and/or parasympathetic stimu-
lants, narcotic drugs are known to cause a broad range of 
long-term cardiac effects and/or acute cardiac arrest (Tong 
et al 2004; Lessa et al 2006). The aim of this study is to 
investigate the pathological changes in the heart of acute 
drug-related fatalities, with a focus on the intervention of 
cardiac MCs, TNF-α, and myocytic cell death compared 
with selected cases who died a sudden natural death (SND). 
To our knowledge, no studies have so far investigated the 
role of these factors in the heart of drug fatalities. More-
over, the observation of pulmonary edema and congestion 
that complicates heroin overdosage, in conjunction with 
increased postmortem levels of tryptase that hitherto has not 
been explained, encouraged us to investigate the distribution 
of inﬁ  ltrated MCs also in the lung of drug fatalities, and 
compare with that of the cardiac tissue in the same group 
versus control group.
Materials and methods
Study subjects
A total number of 50 cases were studied in a retrospective 
case-control study: 30 drug fatalities in which toxicological 
investigation had revealed multiple drug intoxication; and 
20 cases of SND revealed by autopsy or by witnesses and 
other circumstances. Sudden death was deﬁ  ned according to 
the World Health Organization criteria, ie, death within 24 h 
of the onset of symptoms. Before the ﬁ  nal diagnoses were 
determined, the death scene circumstances as well as the 
autopsy, histological, and toxicological ﬁ  ndings were evalu-
ated. Infectious disease, asthma, and other immunologically 
compromising conditions were excluded. The time lapse after 
death until autopsy varied between 1 and 5 days during which 
time the bodies were stored at 4 °C. In all cases, toxicological 
analysis for alcohol and therapeutic drugs (screening test) 
were performed at the National Forensic Chemistry Labo-
ratory Linköping, Sweden. Four autopsied individuals who 
died in a trafﬁ  c accident, with no cardiac lesions as judged by 
histological examination, were included as negative controls 
for the source of myocardial TNF-α.
The autopsies were took place at the departments of 
Forensic Medicine in Linköping and Stockholm, Sweden. In 
all cases, femoral and heart blood were sampled at autopsy. 
Histological sections from the brain, myocardium, lungs, 
liver, kidneys, proximal coronary arteries from the three main 
branches, and laryngeal wall were stained with hematoxylin-
erythrosin-saffron and Mallory’s PTAH. In drug victims, 
additional sections from the thyroid, adrenals, and spleen 
were also stained.
We measured tryptase postmortem in serum from femoral 
vein blood. In order to investigate its association to the num-
ber of inﬁ  ltrated MCs, the drug-related fatalities were divided 
into two groups according to their level of blood tryptase. 
One group included 13 cases with elevated concentrations 
of femoral mast cell tryptase (α + β tryptase) with cut-off 
value set at 45 μg/l (HLT) (Edston et al 2006). The cut off 
value is based on statistical calculations of tryptase values in 
a larger control group. A value above 45 μg/l renders a 5% 
chance of being falsely positive. The other group contained 
17 individuals with low levels of tryptase (LLT), ranging 
between 5–27 μg/l with a mean of 13.4 (± 1.3 SEM). The 
tryptase concentrations in the SND cases ranged between 3 
and 21 μg/l with a mean of 11.6 (± 1.1 SEM).
Determination of tryptase, speciﬁ  c-,
and total-IgE
Femoral blood was sampled in test tubes without additives. 
They were centrifuged, and the serum was frozen at −20 ºC 
until analysis. Alpha and β-tryptase were measured with 
Tryptase FEIA (Pharmacia Diagnostics, Uppsala, Sweden). 
To enable exclusion of any possible immunological com-
plications in drug addicts and SND cases, total serum-IgE Vascular Health and Risk Management 2007:3(6) 1055
Effects of narcotic stimulants on cardiomyocytes
was measured with Pharmacia CAP-system IgE-FEIA and 
morphine-speciﬁ  c IgE with Pharmacia CAP system speciﬁ  c 
IgE-FEIA (Pharmacia Diagnostics, Uppsala, Sweden). The 
analyses were done at the Laboratory of Clinical Immu-
nology and Transfusion Medicine, Karolinska sjukhuset, 
Stockholm, Sweden.
Immunohistochemical analysis
For sequential double labelling with anti-tryptase monoclonal 
antibody (mab) and anti-chymase mab, a method of Irani 
and colleagues (1989), was used to display differentially 
stained MC subsets in the same tissue sections. Sections 
labeled with the antibodies were successively stained with 
the appropriate chromogens to distinguish tryptase and/or 
chymase containing cells by developing different colors. 
Exclusion of streptoavidine, and substitution of this step 
with a secondary antibody that directly conjugated to poly-
peroxidase molecule, improved the staining. By using this 
technique we could differentiate between MCTC, MCT, and 
MCC among the subtypes of MCs.
For each case, four sequential heart-sections from the 
anterior and posterior walls of the left ventricle, the right 
ventricle, the septum, and four lung specimens of both lungs, 
were ﬁ  xed in 4% phosphate-buffered formalin, embedded 
in parafﬁ  n, and cut into sections of 4 μm. All slides were 
deparafﬁ  nized and rehydrated with graded alcohols and 
ﬁ  nally in distilled water. Then they were incubated with 3% 
H2O2 in phosphate-buffer saline (PBS) for 10 min at room 
temperature (RT) and investigated with a retrieval technique: 
pretreated 20 min at RT with trypsine digestion (0.3%, pH 
7.8) in the case of staining with anti-tryptase, and -chymase, 
while 10mM citrate buffer (pH 6.00) was used to reveal the 
epitope of TNF and laminB1 (a nuclear envelope protein). 
This step was followed by 30 min incubation of slides with 
blocking solution (5% bovine serum albumin in PBS) to 
block unspeciﬁ  c bindings. Mabs were applied to the sections 
at a dilution of 1:100 for anti-tryptase and chymase (NOVO 
Castra Laboratories LTD, UK), 1:50 for both anti-TNF-α 
(abcam, UK) and anti-laminB1 (Santa Cruz, INC). Necrosis 
was visualized with an antibody against the terminal comple-
ment complex, ie, C9 (NOVO Castra Laboratories LTD, UK), 
in a dilution of 1:50. All slides were incubated at RT for 60 
min in a moist chamber. After rinsing in PBS, a peroxidase 
conjugated-mouse IgG (NOVO Castra Laboratories LTD, 
UK) as secondary antibody was applied at RT for 30 min. 
The peroxidase activity in tissue sections was visualized by 
utilizing a variety of chromogens. Diaminobenzidine (DAB) 
produces reddish brown precipitate in the sections. This was 
used to detect intracellular chymase, TNF-α, and laminB1 
localization. Vector SG substrate developing a blue-black 
reaction product was used to visualize tryptase in the cell 
sections. Vector VIP peroxidase substrate, which produces 
an intense purple precipitate, was applied to distinguish C9 
cell-attachment. All three chromogenic systems are available 
as kits and purchased from Vector Laboratories, Immunkemi, 
Järfälla, Sweden. The sections were counter-stained with 
light green in the case of MCs subtypes and C9, or Mayer’s 
Hematoxylin, for TNF-α and laminB1 staining. Sections 
without primary antibodies served as negative controls. To 
conﬁ  rm the positive staining of MCs, TNF-α and laminB1, 
sections of spleen, lung, and human tonsil were processed in a 
similar manner as the respective experimental specimens.
To verify the results from immunohistochemical label-
ling of MCs, the tissues were simultaneously stained with 
Toluidine blue for counting mast cells. To confirm the 
results of immunohistochemical labelling of TNF-α, immu-
noﬂ  uorescence staining of parallel sections was performed 
in an Avidin-Biotin system according to the manufacturer’s 
instructions (Vector Laboratories), and the results were 
evaluated in the same manner.
Detection of apoptotic cardiomyocytes
The ApopTag in situ apoptosis detection kit (Chemicon, CA) 
was used according to the manufacturer’s recommendations. 
Apoptotic cells were visualized by means of an anti-digoxi-
genin antibody conjugated to a peroxidase reporter molecule. 
Utilizing DAB as chromogen substrate, we localized the 
bound peroxidase antibody and counterstained these slides 
with a combination of methyl green in 0.1 M sodium acetate. 
The numbers of apoptotic nuclei of cardiomyocytes from the 
same tissue sections as for immunohistochemical analysis 
were determined in a sequence of high power ﬁ  eld (HPF, 
X 400) covering an entire area of one square cm trans-
verse section selected randomly prior to the microscopical 
examination on each slide. These numbers were reported as 
apoptotic nuclei per HPF. Considering the strength of the 
heart to adapt and modify a function or structure to tolerate 
different incidents and their consequences, including cell 
death, we deﬁ  ned a limit based on clinical observations and 
microscopical examination of myocardial apoptosis and 
necrosis. Equal or more than 3 ApopTag-positive myocytic 
nuclei/HFP, or 10 C9-positive myocytes throughout an 
area of 1 square centimeter, was considered as positive for 
apoptosis or necrosis, respectively.
As negative controls, sections were incubated in the 
absence of TdT enzyme. Sections that were digested with Vascular Health and Risk Management 2007:3(6) 1056
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1 μg DNase/ml buffer (Sigma) for 10 min were utilized as 
positive controls. Since nuclear Lamin B is fragmented as a 
consequence of apoptosis, immunological staining of Lamin 
B1 (Freude et al 2000) was performed to validate the result of 
ApopTag analysis. Cardiomyocyte nuclei negative for Lamin 
B1 were counted and calculated similarly as for ApopTag. 
In each case, two independent observers examined all tissue 
sections blindly.
Histomorphometry analysis
of immunostaining
Fifty visual ﬁ  elds per each myocardial section in magniﬁ  ca-
tion × 400 were randomly selected, and all MCTC, MCT, and 
MCC (immunopositive stained cells) were counted by Planopho-
tometry (DP-Soft Imaging System GmbH). The total numbers 
of immunopositive MCs throughout the entire heart sections 
were expressed as numbers of cells per 3 square millimeters. 
Each visual ﬁ  eld per lung section in magniﬁ  cation × 400 was 
randomly chosen, and the numbers of the immunostained cells 
surrounding bronchioles in a total area of 1.5 square millime-
ters were counted. These cells were designated bronchial mast 
cells. Likewise, the equivalent areas in the same slides without 
bronchi were assessed, and the counted-immunoreative cells 
were regarded as parenchymal mast cells. To better evaluate 
the results obtained from the immunohistochemical analysis, 
a group of explanatory parameters were designed for each 
case (refers to Table 4). The sum of both MCTC and MCT 
per tissue area was considered as MCs. By lung MCTC, lung 
MCT, and lung MCC we considered the addition of amount of 
bronchial and parenchymal of these types of cells together. 
By lung MCs, we indicated the sum of both bronchial and 
parenchymal MCTC together with MCT and MCC per tissue 
area. By cardiac MCs we are referring to the sum of MCTC, 
MCC and MCT in heart tissue.
To estimate the cardiac production of TNF-α, four 
sequential sections of the heart of each case were examined 
using the same software (DP-Soft Imaging System GmbH). 
In each case, two independent observers examined all sec-
tions blindly.
Statistical analysis
All statistics were calculated using nonparametric tests. 
Computations of signiﬁ  cances between two groups were per-
formed using the Mann-Whitney U-test. Comparing several 
means, the Kruskal Wallis test was used. For correlations 
within groups, Spearman’s rank correlation test was used. 
All calculations were performed using the statistical package 
Statistica (Statsoft, Scandinavia AB). P  0.05 was regarded 
as signiﬁ  cant. The number of counted MCs was expressed 
as the mean ± SEM per tissue area.
Results
All drug deaths were poly-drug abusers who died from 
acute drug intoxication (Tables 2 and 3). Heroin was the 
last injected drug before death in 21 cases, amphetamine 
in 8, and methadone in a single case. Thus, 73% of all drug 
deaths were associated with recent intravenous injection of 
opioids. Concomitant use of other drugs and alcohol was a 
frequent ﬁ  nding (Table 2, and 3).
Morphopathological ﬁ  ndings in SND
and drug fatalities
In most drug deaths, the heart appeared to be within normal 
limits regarding conﬁ  guration and with weights ranging 
between 231–436 g with a mean of 356 g (±10 SEM, Tables 
2 and 3). In the controls, heart weight varied more (range 
191–654 g) with a mean of 414 g (±29 SEM, Table 1). The 
difference between the groups was not signiﬁ  cant (Kruskal-
Wallis test p  0.05) due to the wide range of the heart weight 
of the control group. In the myocardium, a small number of 
the drug-cases had slight, diffuse ﬁ  brosis and a few, probably 
insigniﬁ  cant, foci of inﬂ  ammatory cells. Apart from conges-
tion, the pathology in the control group was concentrated to 
the heart or the aorta (Table 1). In most drug cases, coronary 
artery disease was absent, and none had more than moderate 
coronary artery sclerosis.
Analysis of tryptase
The results of the tryptase measurements are presented in 
Tables 1, 2, and 3. No speciﬁ  c IgE antibodies to morphine 
were detected in any case. There was a signiﬁ  cant correlation 
between the number of inﬁ  ltrated MCs in the lung sections 
of the HLT group and the femoral blood tryptase concentra-
tion (p  0.05).
Morphometric analysis
of the myocardium and lungs
In pulmonary and cardiac tissues, two populations of MCs 
were apparent: one resembled typical connective tissue 
type MCs that stained with both anti-tryptase and chymase 
(MCTC), and the other was atypical or mucosal MC that 
reacted only to anti-tryptase antibody. This population was 
seen in appreciable amounts in the lung but a minor number 
was found also in heart tissue. Due to a negligible quantity of 
tissue MCC, this subset was excluded from statistical analy-
sis. Signiﬁ  cantly higher amounts of inﬁ  ltrated MCs were Vascular Health and Risk Management 2007:3(6) 1057
Effects of narcotic stimulants on cardiomyocytes
observed in the HLT and LLT-cardiac sections than the other 
groups (p  0.015 Kruskal-Wallis test, Table 4). The number 
of MCTC predominated among the cardiac MCs. Moreover, 
we observed that in 10 cases of 13 (77%) and 4 cases 
of 17 (23.5%) in HLT- and LLT-heart sections, respec-
tively, more than 60% (on average) of the inﬁ  ltrated MCs 
were degranulated (Figure 1b), while none of SND-heart 
sections showed this phenomenon (Table 5). In lung sections 
of drug deaths with high levels of femoral tryptase (HLT), 
there were higher numbers of inﬁ  ltrated MC-subsets at the 
site of bronchial smooth muscle (p  0.05) and parenchymal 
tissues compared with the other two groups (Table 4). No 
signiﬁ  cant differences were seen between the amount of inﬁ  l-
trated MCs in SND cases and drug deaths with low tryptase 
levels (LLT) (Table 4). Figure 1a, showing the inﬁ  ltrated 
MC-subsets in the heart sections, illustrates the differences 
in immunostaining between these cells.
Furthermore, according to our results, the number of 
toluidine-stained MCs was underestimated by approximately 
20% compared with the number of immunologically labelled 
Table 2 Data for the drug fatalities in HLT cases. Age, sex, and autopsy ﬁ  ndings in drug fatalities with high levels of tryptase
Case no.  Age/Gender  Heart weigh  Recently injected drug  Other toxicological ﬁ  ndings  Tryptase
   (g)     (μl/l)
1 39/m 312  heroin  THC  44
2 46/f    amphetamine  ethanol  45
3 36/m 304  amphetamine  benzodiazepines,  THC  46
4 29/m 397  heroin  amphetamine,  THC  48
5 31/m 436  heroin  benzodiazepines  50
6 38/m 434  heroin  benzodiazepines,  propoxyphene  54
7 29/m 292  heroin  benzodiazepines,  ethanol  67.5
8 32/m 335  amphetamine  methadone,  bensodiazepines  71
9 36/m 357  heroin  amphetamine  81
10 26/m  400  amphetamine  THC  86
11 44/m  390  heroin  benzodiazepines,  THC,  ethanol  90
12 35/m  335  methadone  benzodiazepines,  THC  240
13 24/m  320  heroin  amphetamine,  cocaine,  THC,
       benzodiazepines,  stanozolol  477
Abbreviations: THC, tetra-hydro-cannabinol (the active substance in hashish).
Table 1 Data for the SND cases.   Age, sex, and autopsy ﬁ  ndings in 20 cases of sudden natural death
Case no.  Age/Gender  Heart weigh (g)  Diagnosis  Tryptase (μl/l)
       ( α + β)
1 52/m  604  AAD  3
2 59/f  363  AMI  3
3 54/m  654  AAD  6
4 50/m  440  AVA  6
5 40/f  512  HCM  7
6 14/m  312  ARVD  9
7 42/m  370  AMI  9
8 47/f  337  AAD  10
9 27/m  − ARVD  11
10 54/m 364  AMI  11
11 45/m 334  MV  PROLAPSE  12
12 21/m 389  ARVD  13
13 82/m 621  AVA  13
14 42/m 364  AHF  15
15 48/f  318  ARVD  15
16 25/m 323  MYOCARDITIS  15
17 49/m 467  AHF  16
18 13/m 284  ARVD  17
19 54/m 610  MYOCARDITIS  17
20 48/m 191  ARVD  21
Abbreviations: AHF, acute heart failure; AAD, acute aortic dissection; AVA, acute ventricular arrhythmia; ARVD, arrhythmogenic right ventricular dysplasia; AMI, acute 
myocardial infarction; MV, mitral valve; HCM, hypertrophic cardiomyopathy.Vascular Health and Risk Management 2007:3(6) 1058
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cells. Thus the results rest on the immunological labeling of 
antibodies as it found more reliable markers.
Analysis and deﬁ  nition of expression 
patterns of TNF-α
An intriguing result of immunohistochemical analysis of 
TNF-α was the different expression patterns of myocytic 
TNF-α. Two distinctive patterns could be easily identiﬁ  ed; 
one was a patchily dense intracellular production of TNF-α 
and the other a pattern of TNF-α granule-like structures 
spreading throughout the cardiomyocytes. Microscopical 
assessment of four sequential sections of the heart of each 
case revealed different morphological features. The follow-
ing patterns expressing TNF-α production were found: I. An 
intracellular, diffusely scattered pattern of TNF-α granule-
like structures; II. A focal, dense intracellular accumulation of 
TNF-α; III. A focal, dense accumulation with an additional, 
diffusely scattered intracellular distribution of TNF-α 
(Figures 2a, b, c). To evaluate changes in intracellular synthe-
sis of TNF-α, we counted the number of TNF-α granule-like 
structures throughout the entire area of 2 mm2 of sections 
randomly and expressed the change as a percentage of mean 
of diffusely scattered TNF-α granules/2 mm2. In all cases 
of HLT and LLT in whom myocardial MCs were elevated, 
cardiomyocytic production of TNF-α was concomitantly 
increased (%27.4 ± 5 in HLT, and %34.5 ± 3 in LLT com-
pared with SND cases %10 ± 2.7 (%mean ± SEM, Table 5). 
11 of 13 HLT (84.6%) and 8 of 17 LLT cases (47%), but 
only 1 of 20 in the SND, group showed a TNF-α produc-
tion according to pattern type III, indicating a considerable 
difference between these three groups (Table 5). In the 
SND group, 7 of 20 cases (35%) demonstrated focal, dense 
Table 3 Data for the drug fatalities in LLT cases. Age, sex, and autopsy ﬁ  ndings in drug fatalities with low levels of tryptase
Case no.  Age/Gender  Heart weight  Recently  Other toxicological ﬁ  ndings  Tryptase
   (g)  injected  drug    (μl/l)
1 24/m 359  heroin  benzodiazepines,  THC  5
2  26/m  275  heroin  benzodiazepines, cocaine, MDMA  7
3  21/m  394  heroin  amphetamine, benzodiazepines, ethanol  8
4 29/m 304  amphetamine  Ethanol  9
5 21/m 325  heroin  Benzodiazepines  10
6 21/m 312  heroin  benzodiazepines,  ethanol  11
7 51/m 315  heroin  benzodiazepines,  THC,  SRRI  11
8 36/m 335  heroin  benzodiazepines,  ethanol  11
9 20/f  231  heroin  benzodiazepines,  THC  12
10 49/m  410  heroin  Ethanol  13
11 30/m  371  amphetamine  benzodiazepines,  THC,  ethylmorphine  14
12 25/m  394  heroin  benzodiazepines,  THC,  ethanol 14
13 35/m  408  heroin  SRRI  17
14 38/m  361  amphetamine  Tramadol  18
15 27/m  441  heroin  MDMA,  SRRI  19
16 38/m  430  amphetamine  Cocaine  22
17  26/m  433  heroin  metamphetamine, buprenorphine, SRRI  27
Abbreviations: THC, tetra-hydro-cannabinol (the active substance in hashish); MDMA, 3,4-Methylendioxymetamphetamine (colloquially: Ecstasy); SSRI, Selective Serotonin 
Reuptake Inhibitor.
Table 4 Mean number of mast cell-subtype in the lung and heart sections of study subjects
Explanatory parameters  Total area  SND  HLT  LLT
 (mm2) Mean  ± SEM  Mean ± SEM  Mean ± SEM
   N  = 20 N  = 13 N  = 17
Bronchial MCs  1.5  16.6 ± 1.2  31.3 ± 3.2 **  19.3 ± 1
Parenchymal MCs  1.5  11 ± 1  15.2 ± 1.2  13 ± 0.6
Lung MCs  3  27.6 ± 1  46.5 ± 2.2 **  32.3 ± 1.3
Lung MCT 3  5.6  ± 0.8  9.5 ± 1  5 ± 0.4
Cardiac MCs  3  12.8 ± 0.8  18.2 ± 2.8**  17.6 ± 1.1**
Cardiac MCT 3  0.5  ± 0.2  1.2 ± 0.9  1 ± 0.9
Abbreviations: SND, sudden natural death; HLT, high level of postmortal tryptase; LLT, low level of postmortal tryptase.
Note: **Signiﬁ  cant differences according to Kruskal-Wallis Test between three groups.Vascular Health and Risk Management 2007:3(6) 1059
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cardiomyocytic expression of TNF-α only (pattern type II), 
but neither the HLT- nor the LLT-heart sections expressed 
this pattern (Table 5). Additionally, all groups commonly 
showed a certain percentage of myocytic TNF-α according 
to the pattern type I (Table 5). Only one case in LLT stayed 
TNF-α negative. The corresponding cardiac sections obtained 
from the heart of four healthy controls that died in unnatural 
causes stained very few in one case and none in the other 
cases with anti-TNF-α (Figure 2d). Immunoﬂ  uorescence 
staining of this cytokine in cardiac sections demonstrated the 
same pattern as the immunohistochemical staining. In addi-
tion, the endothelium of intramyocardial vessels and almost 
all MCs reacted with anti- TNF-α (Figure 2c).
Detection of apoptosis and necrosis
Classic ApopTag positivity was characterized by focal 
nuclear staining. In apoptotic myocytes nuclear and cell 
membrane integrity was intact (Figure 3a). The overall fre-
quency of cardiomyocytic apoptosis was signiﬁ  cantly higher 
in SND cases: 15 cases of 20 (75%) showed apoptotic nuclei 
(Figure 3a, Table 5). On the other hand, 10 of 13 (77%) drug 
victims with HLT and 16 of 17 (88%) drug overdose fatali-
ties in LLT showed no nuclear staining in cardiomyocyte 
by ApopTag analysis (Table 5). Four heart sections of each 
case were then investigated for binding of C9 antibody to 
the sarcolemma. An intern positive control was found in the 
form of C9-positive material in the walls of the blood vessels 
in every section. Four of 20 (20%) SND cases underwent 
necrosis according to our deﬁ  nition, while this number was 
signiﬁ  cantly higher in drug deaths with LLT, where 9 of 17 
cases (53%) fulﬁ  lled the positive criteria and showed the 
attachment of C9 to the membrane of myocytes (Figure 3b). 
In drug victims with HLT, 4 of 13 cases (30%) were also 
classiﬁ  ed as positive (Table 5).
An excellent correlation was seen between the Apop-
Tag and immunohistochemical analysis with anti-Lamin1B, 
indicating the reliability of the test. Moreover, by sequential 
immunostaining we examined if there was any accumula-
tion of MCs in the vicinity of the ApopTag-positive cardiac 
b
a
Figure 1 (a) Dual immunostaining of anti-tryptase and -chymase in the same mast 
cell located within the interior wall of right ventricle. The insert: Cardiac mast 
cell staining only with anti-tryptase, MCT  . (b) Mast cell degranulation in the heart 
section of a drug victim. Original magniﬁ  cation x 400, in A and x 200 in b.
Table 5 Characterization of TNF-α, cell death and MCs degranulation in the heart of study population 
Study subject  *Total production of  Expression pattern  Cell death    % Cases  
 myocytic  TNFα/2mm2 of  myocytic  TNFα % Cases  **% Cases with   ***% Cases with   with MCs
 mean  ± SEM  I II  III myocytic  myocytic  degranulation
         apoptosis  necrosis 
SND (N = 20)  10 ± 2.7 60  35  5  75  20  0
HLT (N = 13) 27.4  ± 5  15  0  84.6  23  30  77
LLT (N = 17)  34.5 ± 3  47  0  47  12  53  23.5
*The mean number of granule-like structures of new synthesized intracelluar TNF-α.
**3 apoptotic myocyte nuclei /HPF in a total area of 1 Cm2.
***10 necrotic myocytes through an area of 1 Cm2.
I, Intracellular diffusely scattered pattern of TNF-αgranule-like structure.
II, Focal dense intracellular accumulation of TNF-α.
III, Focal, dense accumulation with an additional diffusely scattered intracellular distribution of TNF-α granule-like structures.Vascular Health and Risk Management 2007:3(6) 1060
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myocytes in the heart sections. The results showed no 
signiﬁ  cant accumulation of MCs into the neighborhood of 
the apoptotic myocytes.
Discussion
The most interesting result of this study is the production 
of cardiac TNF-α and different expression patterns of this 
cytokine, which was found to be synthesized in the cardio-
myocytes. These ﬁ  ndings are unexpected but logical, as it 
is known that TNF-α exerts endocrine, paracrine, and auto-
crine controls of inﬂ  ammatory responses during the course 
of diseases (Sherry et al 1988). Moreover, according to our 
results healthy hearts showed almost absence of myocytic 
TNF-α expression.
An estimation of the correlations between the MCs, 
TNF-α, and apoptosis in the myocardium revealed that drug 
overdose victims exhibited signiﬁ  cantly increased inﬁ  ltration 
of MCs with a high degree of activation and degranulation, 
over-expression of cardiomyocytic TNF-α, mostly in patchy 
and diffuse form as deﬁ  ned in pattern type III, and an overall 
negativity for myocytic apoptosis. Moreover, the heart of 
the drug fatalities exhibited increased incidence of myocytic 
necrosis compared with SND. Examination of the myocardial 
sections in SND showed no degranulation of tissue MCs, 
relatively moderate TNF-α expression (%10 ± 2.7), and a 
signiﬁ  cant number of cases exhibited myocytic apoptosis. 
The former result agrees with the result of one of our previ-
ous studies (Edston et al 2002).
Apoptosis is a time-dependent deterioration of the myo-
cardium. Experimentally, after the initial stimulus, the ﬁ  rst 
apoptotic phenomena are measurable 2 h after initiation, 
and the ﬁ  rst signs of DNA fragmentation appear at 9 h after 
stimulation and subsequently, after 14 h apoptotic nuclei 
characterized by TUNEL/ApopTag (Rodriguez et al 2005). 
This indicates that in sudden death of cardiac or vascular ori-
gin, an ischemic or other challenge to the heart ought to have 
happened some time before the occurrence of the lethal ven-
tricular arrhythmia. However, the lack of apoptosis in acute 
drug deaths indicates that such deaths occur very shortly after 
the drug injection. Unfortunately, those few cases of drug 
deaths that displayed some degree of apoptotic nuclei were 
unwitnessed deaths, where the duration of the agonal phase 
is not possible to ascertain. While the attachment and detach-
ment of circulating complement components to cell surfaces 
occurs continuously, the binding to necrotic myocytes can be 
detected 1–3 h after the challenge (Edston 1997).
a b
d c
Figure 2 Immunohistochemical analysis of TNF-α in endomyocardial tissues obtained from drug-related victims (a and c) and SND (b). Overview of transverse sections 
with cytoplasmic localization of newly synthesized myocytic TNF-α of pattern type I (a) and II (b). The longitudinal section (c) showing intracellular production of TNF-α
of pattern type III in cardiomyocytes. TNF- α protein was also present in cardiac MCs (arrows).   Analysis of TNF-α in longitudinal section of endomyocardial tissues obtained 
from a healthy control that died in unnatural causes (d). Original magniﬁ  cation x 200.Vascular Health and Risk Management 2007:3(6) 1061
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In addition, histopathological examination of the heart 
of SND cases demonstrated a signiﬁ  cantly dissimilar proﬁ  le 
despite the fact that the blood tryptase occasionally over-
lapped that of the drug victims with LLT. In accordance with 
the result of the previous study (Perskvist et al 2006), the 
mean number of MCs in the heart sections of victims who 
died from known causes, eg, suicide by hanging and trafﬁ  c 
accidents, showed almost the same amount of inﬁ  ltrated 
cells compared with that of the MCs in SND cases. Thus, 
the signiﬁ  cant increase of inﬁ  ltrated cells in the heart of drug 
victims might be a chronic effect of repeated intravenous 
drug injections.
Previously, we have demonstrated a signiﬁ  cant augmen-
tation of inﬁ  ltrated MCs in heart sections of anaphylactic 
deaths, a high level of serum mast cell tryptase and a severe 
degree of pulmonary congestion and edema (Perskvist et al 
2006). In this study histopathological analysis of HLT drug 
deaths shows similarities to that in victims of anaphylactic 
shock, supporting the hypothesis that the pathogenic mecha-
nism behind the drug-related deaths involves systemic activa-
tion of mast cells, as the inﬁ  ltration of MCs was signiﬁ  cantly 
higher also in the heart and lung in this group. The degree of 
degranulation of MCs in the heart of the HLT was similar 
to that anaphylactic degranulation in the subjects of our 
previous study (Perskvist et al 2006). Thus, we suggest that 
in situ degranulation and discharge of MCs mediators into 
the interstitial spaces of the myocytes, where it may locally 
provoke coronary spasm, may contribute to more fatal cardiac 
disturbances than the density of the intact cells. Furthermore 
the lack of speciﬁ  c IgE against morphine in serum of heroin-
related deaths gives no support for classic anaphylaxis in 
those cases. Also, the discovery that deaths by injection of 
psycho-stimulants (amphetamine) produced elevated tryptase 
values, and were morphologically indistinguishable from the 
heroin deaths, points to a non-IgE mediated mast cell acti-
vation. It cannot be ruled out that a few of our cases might 
have had an allergic disposition or an increased incidence of 
asthma. It has not been possible to extract such background 
information on the subjects of this study.
The action of TNF-α are mediated by its binding to one 
of two speciﬁ  c receptors, TNF-α receptor 1 and 2 express 
among the others on the surface of cardiomyocytes (Vassalli 
1992). We propose that the different pattern of myocytic 
production of TNF-α may be dependent on the engagement 
or the level of expression of the type of TNF-α receptors, 
but this remains to be investigated.
In agreement with our ﬁ  nding, it has been demonstrated 
previously that the failing heart can produce TNF-α, which in 
excessive levels can promote left ventricular remodelling and 
may have negative inotropic effects (Torre-Amione 1995). 
Overproduction of TNF-α may aggravate the syndrome of 
heart failure by inducing peripheral deleterious responses. 
TNF-α receptors then can be detected and measured as 
soluble factors. These measurements give accurate estimation 
of the activity of TNF-α in chronic heart failure (Ferrari et al 
1995). TNF-α is involved in the triggering and/or ampliﬁ  ca-
tion of local inﬂ  ammatory responses, eg, apoptotic cascade, 
related to ischemia-reperfusion injury in patients with acute 
myocardial infarction (Blancke et al 2005). We propose that 
repeated intravenous injection and drug intoxication both of 
opiates and psychostimulants induce a profound inﬁ  ltration 
of MCs in the heart. In certain conditions an acute challenge 
b
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Figure 3 (a) TUNEL-positive myocytes nuclei (brown) demonstrated with the 
ApopTag kit. The transverse section is from the left ventricle in a case of SND 
(x 200 magniﬁ  cations). The insert: Higher magniﬁ  cation (x 400) of the same section 
showing complete labelling of myocytes nuclei. (b) Myocytic necrosis visualized by 
the binding of antibody against the terminal complement complex (purple) to the 
sarcolemma. The longitudinal is from the left ventricle in a case of LLT group (x 200 
magniﬁ  cation).Insert: Higher magniﬁ  cation (x 400) of the same section showing 
immunoreactivity of cardiac myocytes to the C9-mab. The endothelium of intra-
myocardial vessels also reacted with C9-ab and used as an internal control (arrow).Vascular Health and Risk Management 2007:3(6) 1062
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may lead to fatal activation and degranulation of MCs, lung, 
and vascular tissues. Initially, release of histamine induces 
vasodilatation and increased vascular permeability causing 
hypotension and decreased cardiac output. Subsequently, 
vasoconstriction compounds are released locally and in the 
peripheral circulation. These mediators are able to induce 
coronary spasm progressing to acute myocardial ischemia, 
heart failure, and ventricular ﬁ  brillation. In addition, either 
the discharged MC-compounds or the circulating drug stimu-
late the overproduction of TNF-α in cardiomyocytes that 
contributes to the deterioration of the pumping function of 
the heart. Moreover, if the subject survives the initial events, 
TNF-α may induce an apoptotic and/or necrotic cascade of 
the myocytes and interstitial cells.
In conclusion the link between cardiac mast cells, TNF-α, 
and a number of pathological processes suggest that anti-his-
tamine and anti-TNF-α therapies may have a beneﬁ  cial effect 
on the cardiac effects and thus of morbidity and mortality 
after acute intravenous drug injection.
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